84 related articles for article (PubMed ID: 21413852)
21. Treatment of stage I seminoma: a 15-year review.
Alomary I; Samant R; Gallant V
Urol Oncol; 2006; 24(3):180-3. PubMed ID: 16678046
[TBL] [Abstract][Full Text] [Related]
22. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
23. [Does radiotherapy still have a place in the treatment of stage I seminoma?].
Paule B
Prog Urol; 2004 Jun; 14(3):281-6; discussion 285-6. PubMed ID: 15373167
[TBL] [Abstract][Full Text] [Related]
24. Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT.
Albuquerque K; Giangreco D; Morrison C; Siddiqui M; Sinacore J; Potkul R; Roeske J
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1043-7. PubMed ID: 20471182
[TBL] [Abstract][Full Text] [Related]
25. Is "optimal" radiation for stage I seminoma yet defined?
Thomas GM
J Clin Oncol; 1999 Sep; 17(9):3004-5. PubMed ID: 10561381
[No Abstract] [Full Text] [Related]
26. [Comparison of prognosis between inguinal cryptorchic seminoma and scrotal seminoma].
Li Y; Qian T; Yu Z
Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):74-5. PubMed ID: 10921067
[TBL] [Abstract][Full Text] [Related]
27. Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma.
Centola GM; Keller JW; Henzler M; Rubin P
J Androl; 1994; 15(6):608-13. PubMed ID: 7721664
[TBL] [Abstract][Full Text] [Related]
28. Second primary cancer in irradiated stage I testicular seminoma.
Stein ME; Steiner M; Lachter J; Kessel I; Moskovitz B; Kuten A
Strahlenther Onkol; 1993 Nov; 169(11):672-7. PubMed ID: 8248844
[TBL] [Abstract][Full Text] [Related]
29. Online MRI guidance for healthy tissue sparing in patients with cervical cancer: an IMRT planning study.
Kerkhof EM; Raaymakers BW; van der Heide UA; van de Bunt L; Jürgenliemk-Schulz IM; Lagendijk JJ
Radiother Oncol; 2008 Aug; 88(2):241-9. PubMed ID: 18490068
[TBL] [Abstract][Full Text] [Related]
30. T2 relaxation times of irradiated vertebral bone marrow in patients with seminoma.
Argiris A; Maris T; Vlahos L
Magn Reson Imaging; 1997; 15(3):335-40. PubMed ID: 9201681
[TBL] [Abstract][Full Text] [Related]
31. Dose to bone marrow using IMRT techniques in prostate cancer patients.
Gershkevitsh E; Clark CH; Staffurth J; Dearnaley DP; Trott KR
Strahlenther Onkol; 2005 Mar; 181(3):172-8. PubMed ID: 15756521
[TBL] [Abstract][Full Text] [Related]
32. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
Hein PA; Gladstone DJ; Bellerive MR; Hug EB
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
[TBL] [Abstract][Full Text] [Related]
33. Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: a report on Medical Research Council Trial TE18, European Organisation for Research and Treatment of Cancer Trial 30942 (ISRCTN18525328).
Chan R
J Clin Oncol; 2005 Sep; 23(27):6806; author reply 6806-7. PubMed ID: 16170196
[No Abstract] [Full Text] [Related]
34. Surveillance in stage I testicular seminoma.
Chung P; Warde P
Urol Oncol; 2006; 24(1):75-9. PubMed ID: 16414499
[TBL] [Abstract][Full Text] [Related]
35. Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma.
Simone CB; Kramer K; O'Meara WP; Bekelman JE; Belard A; McDonough J; O'Connell J
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):242-9. PubMed ID: 21236595
[TBL] [Abstract][Full Text] [Related]
36. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy.
Buyyounouski MK; Horwitz EM; Uzzo RG; Price RA; McNeeley SW; Azizi D; Hanlon AL; Milestone BN; Pollack A
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1383-91. PubMed ID: 15275723
[TBL] [Abstract][Full Text] [Related]
37. Prognosis of primary testicular seminoma: a report on 57 new cases.
Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
Cancer Res; 2000 Apr; 60(8):2152-4. PubMed ID: 10786678
[TBL] [Abstract][Full Text] [Related]
38. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].
Huang XB; Jiang GL; Chen JY; Chen LF; Hu WG
Ai Zheng; 2006 Jul; 25(7):855-60. PubMed ID: 16831277
[TBL] [Abstract][Full Text] [Related]
39. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
40. Adverse effects after radiotherapy for early stage (I,IIa,IIb) seminoma.
Majewski W; Majewski S; Maciejewski A; Kolosza Z; Tarnawski R
Radiother Oncol; 2005 Sep; 76(3):257-63. PubMed ID: 15921773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
